Trelegy Ellipta
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Trelegy Ellipta." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110436/0/Trelegy_Ellipta.
Vallerand AHA, Sanoski CAC. Trelegy Ellipta. Davis's Drug Guide. F.A. Davis Company; 2026. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110436/0/Trelegy_Ellipta. Accessed June 26, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Trelegy Ellipta. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110436/0/Trelegy_Ellipta
Vallerand AHA, Sanoski CAC. Trelegy Ellipta [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 26]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110436/0/Trelegy_Ellipta.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Trelegy Ellipta
ID - 110436
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110436/0/Trelegy_Ellipta
PB - F.A. Davis Company
ET - 20
DB - Medicine Central
DP - Unbound Medicine
ER -

Davis's Drug Guide

